483
N.Y.S. Psychiatric Institute IRBN.Y.S. Psychiatric Institute IRB – FDA 483, Feb 2, 2023
Record Details
The N.Y.S. Psychiatric Institute IRB in New York, NY, was cited for multiple deficiencies related to its oversight of human subject research. Observations included failures to report serious noncompliance and unanticipated problems, inadequate informed consent documents, improper use of expedited review, and issues with IRB meeting quorum and composition. These findings indicate significant deviations from regulatory requirements for institutional review boards.
View Company Profile
ID · 9ee0a8d2-9e18-40d5-9593-3bb476ed7a23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.